Personally, I feel that Fipon Bio is okay.
Philponix is a well-known in-vitro diagnostics platform company, focusing on the future needs of people's health management and biotechnology development trends, providing global in-vitro diagnostics companies with excellent performance of IVD reagents with core raw materials, reagent solutions and open instrumentation platforms. Based on the in-depth understanding of the industry development trend, we provide open instrument platforms and reagent total solutions to serve global diagnostic companies and testing organizations.
Fipon Bio understands that the medical industry has changed from "treating the disease" to "preventing the disease", and has built a comprehensive and perfect technology platform for in vitro diagnostics, independently developed and launched 1200+ core raw materials including antigens, antibodies, enzymes, etc., which are widely used in immunoassay, immunoassay, immunosuppressant, immunocompatibility and immunoassay. We have independently developed and launched 1200+ core raw materials, including antigens, antibodies, enzymes, etc., which are widely used in immunodiagnosis, biochemical diagnosis, molecular diagnosis and high-throughput sequencing, helping early diagnosis and early screening of diseases and accurate diagnosis.
Related Information
Fipon Bio expects to continue to innovate its products and services, and promote the development of the diagnostic industry in the form of a diagnostic ecosystem with its partners **** to realize the goal of "making diagnosis earlier, more accurate, and more precise. We are committed to realizing the mission of "making diagnosis earlier, more accurate, more convenient and cheaper". Fipon Bio started from the core raw materials of in vitro diagnostic reagents, and has gradually established a comprehensive technology platform in the course of more than 20 years of development.
Breaking the situation of domestic bioactive proteins relying on imports, and in the deep accumulation of technology to gradually form the reagent core raw materials, reagent solutions, open instrumentation platform. 2020, the beginning of the epidemic outbreak of the new crown, Fipon Bio rapid action, in late January to establish the anti-epidemic emergency response team, and quickly launched the product research and development of research and development work, and the first to implement the new crown in the industry, the donation of raw materials for the detection of reagents. The company is also the first in the industry to implement the donation of raw materials for the new crown test reagents, which will help prevent and control the epidemic with its continuous actions.